
Sanjiv Shah MD FAHA, FACC
Echocardiography, Heart Failure & Transplantation
Stone Endowed Professor in Medicine-Cardiology, Northwestern University Feinberg School of Medicine
Join to View Full Profile
675 N Saint Clair StSuite 19-100Chicago, IL 60611
Phone+1 312-695-4965
Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- HFpEF, cardiac amyloid, pulmonary hypertension, clinical trials, clinical physiologic studies (deep phenotyping), machine learning, precision therapeutics
Education & Training
- University of ChicagoFellowship, Cardiovascular Disease, 2006 - 2007
- University of California (San Francisco)Fellowship, Cardiovascular Disease, 2004 - 2006
- University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
- Northwestern University The Feinberg School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2002 - Present
- FL State Medical License 2024 - Present
- IL State Medical License 2006 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Ranolazine and Pulmonary Hypertension Start of enrollment: 2010 Jun 01
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial Start of enrollment: 2011 Sep 15
- Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction Start of enrollment: 2014 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease.John W Ostrominski, Brian L Claggett, Zi Michael Miao, Gerasimos Filippatos, Akshay S Desai
Diabetes Care. 2025-05-01 - Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial.Jawad H Butt, Pardeep S Jhund, Alasdair D Henderson, Brian L Claggett, Akshay S Desai
European Journal of Heart Failure. 2025-04-13 - Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial.Jawad H Butt, Pardeep S Jhund, Alasdair D Henderson, Brian L Claggett, Akshay S Desai
European Journal of Heart Failure. 2025-04-10
Journal Articles
- Clinical Research Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients with Preserved Ejection FractionSanjiv J Shah, Dalane W Kitzman, Barry A Borlaug, Daniel Burkhoff, ScienceDirect
- Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients with Heart Failure with Preserved Ejection FractionGregory D Lewis, David J Whellan, Martin M LeWinter, Margaret M Redfield, Andrew L Smith, Eugene Braunwald, Michael M Givertz, Adrian F Hernandez, Sanjiv J Shah, Horng..., JAMA
- Clinical Research History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart FailureJaved Butler, Margaret M Redfield, Adrian F Hernandez, Muthiah Vaduganathan, Ravi B Patel, Sanjiv J Shah, ScienceDirect
- Join now to see all
Lectures
- CorviaCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/12/2019
- Corvia for HFpEF (REDUCE LAP II)CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
- Iatrogenic ASD Devices for Heart Failure: Proof of Principle and Potential Impact on Patient Care2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Join now to see all
Press Mentions
- Exploring the Link Between Inflammation and Heart DiseaseApril 1st, 2025
- Duke Heart Pulse — February 23, 2025February 23rd, 2025
- FDA Clears AI Screening Tool for Cardiac AmyloidosisNovember 20th, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: